AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

Processa Pharmaceuticals, Inc. Director's Dealing 2020

Oct 16, 2020

35172_dirs_2020-10-16_32dd159f-cf52-40eb-b987-337a3a585ba4.zip

Director's Dealing

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Processa Pharmaceuticals, Inc. (PCSA)
CIK: 0001533743
Period of Report: 2020-10-06

Reporting Person: Floyd Robert Michael (Chief Operating Officer)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	26000	Direct
Common Stock	103851	Indirect